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Communicating Personalized Cancer Statistics: Challenges and Opportunities 
After a cancer diagnosis, many patients want truthful and complete disclosure of cancer 
statistics, such as estimation of life-expectancy (Fletcher et al., 2017). Such statistical 
information might help increase patients’ understanding of diagnosis and involvement in a 
shared decision making process with their doctor about treatment (Elwyn et al., 2017). Even 
though cancer statistics have been communicated through various sources (e.g., decision aids 
or cancer websites), they are currently limited for a number of reasons.  
First of all, cancer statistics are typically generic and not personalized, mostly because 
they are based on statistics of groups of prior patients. This makes it hard for patients to apply 
the statistics to their own situation (van Stam & van der Poel, 2017). Secondly, cancer statistics 
are difficult to maintain and are not always based on the most recent evidence, especially in 
paper-based decision aids. In this case, such numbers potentially do more harm than good 
(Montori et al., 2012). Finally, statistics expressed as percentages or probabilities are difficult 
to understand for the general public, and are not always communicated in a patient-friendly 
way (Gigerenzer et al., 2007).   
However, using both insights from risk communication and developments in data 
science and artificial intelligence, the goal of our project is to tackle these issues. More 
specifically, we analyze data of millions of Dutch cancer patients in order to determine various 
personalized statistical information for individual cancer patients. Based on these analyses, we 
develop a tool which automatically generates personalized multimodal reports of the statistical 
information, in a format that is both accessible and understandable for patients.  
The data used for this project come from the Netherlands Cancer Registry (NCR), which 
tracks all new cancer diagnoses and contains information about diagnosis, (e.g., tumor 
characteristics), treatment and vital status of patients. Similar population datasets have also 
been used elsewhere for prognostic tools (Henton et al., 2017). The scope of the current project 
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was restricted to the most frequently diagnosed forms of cancer in The Netherlands: prostate, 
breast and colon cancer. Before building the tool, several focus groups with patients (N = 19) 
and meetings with health professionals have been conducted to gauge their wishes and 
information needs, and also to receive feedback on the first sketches of the tool. Based on this, 
it was decided to disclose three types of cancer statistics as a starting point: incidence, survival, 
and conditional survival rates.   
The tool will be installed at the Dutch cancer website (www.kanker.nl), on which 
patients can already view general cancer statistics based on the NCR. Additionally, our tool 
provides patients the opportunity to enter both personal (e.g., age) and disease-related 
characteristics (e.g., tumor stage) for receiving statistics based on patients with similar traits. 
The personalized statistics will be automatically communicated on a short result page for which 
we make use of a data-to-text system and natural language generation techniques (Gatt & 
Krahmer, 2018). These statistics are explained in a multimodal way, using both non-technical 
language combined with several types of visualization (e.g., icon arrays, bar charts, or line 
graphs), in accordance with guidelines and best practices from the risk communication literature 
(Garcia-Retamero & Cokely, 2017). Additional focus group and usability testing studies with 
both patients (breast, prostate and colon cancer) and doctors are currently being conducted.  
However, during the development of the tool, several challenges have been 
encountered. First, although we expect that personalized statistics will be perceived as more 
relevant, and hence better processed than generic information, we should not underestimate the 
role of affect in this process (Zikmund-Fisher et al., 2010). However, studies show that for those 
patients who really want honest prognostic information the levels of hope maintain, even when 
the news is bad (Smith et al., 2010). The second challenge deals with communicating 
uncertainty. The estimated numbers we provide are based on prior cancer patients with similar 
traits and, inevitably, yield some degree of uncertainty. Although risk communication experts 
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recommend disclosing uncertainty to patients (Politi et al., 2007), it is still unclear whether 
patients really benefit from this information (Engelhardt et al., 2017). A final challenge relates 
to the automatic explanations generated, and particularly how to tailor sentences and 
explanations on poor prognosis and treatments with seemingly similar responses but various 
side-effects.     
To conclude, shared decision making in cancer care requires that patient and doctor are 
both well-informed about the clinical case and personal situation at hand. We believe that our 
personalized approach of sharing timely, reliable, and relevant cancer statistics can play an 
important role in this.    
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